Did you know that your browser is out of date?
For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
Medical device manufacturers and technology companies face a rapidly evolving regulatory and business environment, underscored by new mergers and partnerships between medical device and medical technology companies, increased regulatory scrutiny, rapid technological advancement, and growing cybersecurity threats.
Antitrust
As with any growing industry, we expect the medical device and technology fields to experience a surge in competition-related claims and antitrust concerns. NERA has provided assistance to clients involved in antitrust claims for half a century. Our experts combine institutional knowledge of the medical device market and a rigorous economic approach with a deep understanding of antitrust and competition law. The following are select examples of NERA services provided to our medical device clients:
Intellectual Property
NERA’s intellectual property economists apply thorough analysis in IP disputes to determine damages in connection with infringement and breach-of-contract claims involving patents and trade secrets for clients in the medical device industry. We also work with clients to address such issues as irreparable harm and the impact of alleged false or misleading advertising. Beyond this, our consultants work with medical device clients to value IP in connection with selling or licensing negotiations, preparing required transfer pricing documentation, obtaining advanced approval from a tax authority for the price of a particular trade flow or resolving a tax controversy. We help our clients identify portions of their IP portfolios that have value, develop strategies to manage risk, and use their IP for strategic advantage in the marketplace. The following are recent examples of our work:
Product Liability and Mass Torts
NERA economists work with medical device companies on projects related to product recalls, damages claims, insurance disputes, mergers and acquisitions and consumer class actions. Examples of recent matters include:
Securities
NERA’s securities and finance economists work with clients in the medical device and medical equipment industries to address allegations of product liability and securities fraud, to assist in resolving commercial disputes, and to manage financial, legal, and securities risks. Examples of recent matters include:
Transfer Pricing
Based throughout Europe and the US, NERA’s transfer pricing economists provide clients in the medical device and medical technology industries with expert analysis, valuation support, and advice on domestic and cross-border tax and valuation matters, and serve as expert witnesses in tax litigation and arbitration matters. Examples of recent work include:
Name | Title | Location | Phone | |
---|---|---|---|---|
Dr. Lawrence Wu | President | San Francisco | +1 415 291 1007 | lawrence.wu@nera.com |
Sarah Butler | Managing Director | San Francisco | +1 415 291 1022 | sarah.butler@nera.com |
Dr. Yves Hervé | Managing Director | Frankfurt | +49 69 710 447 508 | yves.herve@nera.com |
Dr. Vinita Juneja |
Managing Director
Chair of NERA's White Collar, Investigations and Enforcement Practice |
New York City
London Toronto |
+1 212 345 3148
+44 20 7659 8618 +1 416 868 7314 |
vinita.juneja@nera.com |
Dr. Christine Siegwarth Meyer |
Managing Director
Chair of NERA's Intellectual Property Practice |
White Plains, NY | +1 914 448 4119 | christine.meyer@nera.com |
Dr. Lauren Stiroh |
Managing Director
Chair of NERA's Global Antitrust and Competition Practice |
White Plains, NY | +1 914 448 4143 | lauren.stiroh@nera.com |
Dr. David Blackburn | Director | Washington, DC | +1 202 466 9264 | david.blackburn@nera.com |
Kristopher Boushie | Director | Washington, DC | +1 202 466 9228 | kristopher.boushie@nera.com |
Bradley A. Heys | Director |
Toronto
New York City |
+1 416 868 7312
+1 212 345 2691 |
brad.heys@nera.com |
Mary Elizabeth C. Stern | Director | White Plains, NY | +1 914 448 4054 | mary.elizabeth.stern@nera.com |
Dr. Chris Stomberg | Associate Director | Washington, DC | +1 202 466 9219 | chris.stomberg@nera.com |
Dr. Paul Wong | Associate Director | Los Angeles | +1 213 346 3026 | paul.wong@nera.com |
Dr. Alan Cox | Affiliated Consultant | San Francisco | +1 415 291 1000 | alan.cox.affiliate@nera.com |
Dr. Thomas McCarthy | Affiliated Consultant | Los Angeles | +1 213 346 3000 | thomas.mccarthy.affilate@nera.com |
Title | Type | Author | ||
---|---|---|---|---|
Snapshot of Recent Trends in Asbestos Litigation: 2020 Update | Report | Mary Elizabeth C. Stern and Lucy P. Allen | ||
Antitrust Considerations for Biosimilar Reverse Payment Litigation – Not So Similar A... | Published Article | Dr. Sheng Li | ||
Drug Rebates: A Peek Behind the Curtain at Drug Prices | Published Article | Dr. Christopher Stomberg | ||
Snapshot of Recent Trends in Asbestos Litigation: 2019 Update | Report | Mary Elizabeth C. Stern and Lucy P. Allen | ||
Snapshot of Recent Trends in Asbestos Litigation: 2018 Update | White Paper | Mary Elizabeth C. Stern and Lucy P. Allen | ||
Paper Trail: Review of a Recent Working Paper on the Effect of Copay Coupons on Drug ... | Published Article | Bryan Ray and Dr. Subbu Ramanarayanan | ||
|
Title | Date | |||
---|---|---|---|---|
NERA Insights Webinar Series: Intellectual Property | 19 November 2020 | |||
Women Leaders in Life Sciences Law | 18 November 2020 | |||
NERA Insights Webinar | Trends in Pharmaceutical Patents and the Potential Impact of ... | 17 November 2020 | |||
Economic Trends in Pharma | 30 October 2020 | |||
NERA Insights Webinar | Navigating Antitrust Concerns in Biosimilar Patent Settlement... | 29 September 2020 | |||
Summit on Biosimilars & Innovator Biologics | 23 September 2020 | |||
Meet the Author: Trends in Patent Density | 20 August 2020 | |||
Life Sciences Accounting and Reporting Congress | 10 August 2020 | |||
Concurrences and Fordham Law: Antitrust in Life Sciences | 01 July 2020 | |||
2nd Annual GCR Live: Pharmaceuticals | 27 February 2020 | |||
Title | Date | Type | ||
---|---|---|---|---|
Global Transfer Pricing Expert Joins NERA Economic Consulting | 10 September 2020 | Press Release | ||
NERA Economic Consulting Announces Senior-Level Promotions | 19 March 2019 | Press Release | ||
|